Coding Tip: Z Code Reporting for COVID-19
RHIA, CDIP, CCS, CCS‑P, CIRCC
Executive Director Of Education
AHIMA‑Approved ICD‑10‑CM/PCS Trainer and Ambassador
Updated 7/27/20 Please see updated notes in red font.
Just a few reminders on coding for COVID-19 when the test results are NOT positive. Obviously any positive test result documented in the record for COVID-19 would be coded to U07.1, COVID-19.
If the facility does a COVID-19 test, and test is negative, do I need a diagnosis code?
The answer is yes, you will report a Z-code. For any patient receiving a COVID-19 test, if negative, there MUST be a Z-code to describe why the test was taken. (Test negative for COVID-19 and MD does not override negative results).
The codes to use were described in the original COVID19 FAQ prior to the release of the FY2021 OCG. In addition, on 7/24/20 HIA has received an answer back to a letter inquiring if Z20.828 (Z20.822 after 1/1/2021) should be used for ALL testing for COVID-19 with negative test results, regardless of symptoms or no symptoms, documented exposure or not. AHA has responded that “It was advised that it is appropriate to assign code Z20.828, Contact with and (suspected) exposure to other viral communicable diseases (Z20.822 after 1/1/2021), as an additional code when a patient is screened or tested (pre-operatively) for COVID-19 and the test is negative.” Also they stated that per guideline I.C.21.c.1 Contact/Exposure, Z20 codes may be used for patients who are in an area where a disease is epidemic and there is concern that the patient may have been exposed to the disease. Code Z20.828 (Z20.822 after 1/1/2021) may be assigned without explicit documentation of exposure or suspected exposure to COVID-19. The patient does not have to exhibit sign and symptoms associated with COVID-19. See below OCG for FY2021:
*In early July, CDC released the FY2021 ICD-10-CM Official Guidelines for Coding and Reporting effective October 1, 2020. In the below you will see that the advice has changed from what was provided in the AHA FAQ document. Please see (f) Screening for COVID-19 below. The advice states that now for screening for COVID-19 and negative test result, regardless of symptoms, should be coded Z20.828 and not Z11.59 (Z11.52 after 1/1/2021) or Z03.818 as these are considered screening codes. The reason is that we are in a COVID-19 pandemic and the screening codes would no longer apply. Some facilities have decided to implement the below advice now. HIA had sent a letter to AHA regarding this information in June, that was also sent to the EAB and we are still awaiting reply.
ICD-10-CM Official Guidelines for Coding and Reporting FY 2021 Page 31 of 126
(e) Exposure to COVID-19
For asymptomatic individuals with actual or suspected exposure to COVID-19, assign code Z20.828, Contact with and (suspected) exposure to other viral communicable diseases. (Z20.822 after 1/1/2021)
For symptomatic individuals with actual or suspected exposure to COVID-19 and the infection has been ruled out, or test results are inconclusive or unknown, assign code Z20.828, Contact with and (suspected) exposure to other viral communicable diseases (Z20.822 after 1/1/2021). See guideline I.C.21.c.1, Contact/Exposure, for additional guidance regarding the use of category Z20 codes.
If COVID-19 is confirmed, see guideline I.C.1.g.1.a
(f) Screening for COVID-19
During the COVID-19 pandemic, a screening code is generally not appropriate. For encounters for COVID-19 testing, including preoperative testing, code as exposure to COVID-19 (guideline I.C.1.g.1.e).
Coding guidance will be updated as new information concerning any changes in the pandemic status becomes available.
Where in the record is it?
Coders will need to research their facility’s record on where to find orders for COVID-19 testing, laboratory results for COVID-19 and documentation of results. Usually test results are documented in the progress notes, but not always. Each facility is unique in where COVID-19 test orders are so be sure you know where they are. Coders should really be looking for these orders and tests as more and more facilities are testing patients for COVID-19. In some electronic health records, the coder can search by typing in “COV” in the search box and every instance of documentation of it in the record will come up for review.
COVID-19 Code Validation
Some facilities are validating the coding of every COVID-19 patient. If so, the coder must be sure to follow facility protocols on pending or referring the record for review.
History of COVID-19
If a patient has a history of COVID-19, and has no signs, symptoms and no manifestations of COVID-19 any longer, assign the history code Z86.19, Personal history of other infectious and parasitic diseases (Z86.16 after 1/1/2021). There is not a timeframe for the history code so coders will need to review documentation carefully.
Follow-up visits after COVID-19 infection has resolved
(j) Follow-up visits after COVID-19 infection has resolved
For individuals who previously had COVID-19 and are being seen for follow-up evaluation, and COVID-19 test results are negative, assign codes Z09, Encounter for follow-up examination after completed treatment for conditions other than malignant neoplasm, and Z86.19, Personal history of other infectious and parasitic diseases.
Antibody Testing for COVID-19 Only
For an encounter for antibody testing that is not being performed to confirm a current COVID-19 infection, nor is a follow-up test after resolution of COVID-19, assign Z01.84, Encounter for antibody response examination.
Follow the applicable guidelines above if the individual is being tested to confirm a current COVID-19 infection.
Below is the advice used PRIOR to this directive we received from AHA:
Three Z codes to choose from:
These codes were described in the original COVID19 FAQ prior to the release of the FY2021 OCG:
Z20.828, Contact with and (suspected) exposure to other viral communicable diseases is assigned when a patient exhibits signs and symptoms of COVID-19 and COVID-19 is suspected, and COVID-19 test is negative. The symptoms or reason for symptoms would be coded followed by the Z20.828 code.
Z03.818, Encounter for observation for suspected exposure to other biological agents ruled out is assigned when there is NO symptoms or signs of COVID-19 however the patient was documented as being exposed to COVID-19. Examples include the patient coming in contact with another patient with COVID-19 or some other type of exposure. The key here is that there is exposure or suspected exposure to COVID-19. When the test is negative assign Z03.818 to show that the patient was exposed to COVID-19, had no symptoms, and the testing was negative.
Z11.59, Encounter for screening for other viral diseases is used for a patient who presents for COVID-19 testing and has no symptoms and no exposure, and test is negative. Early on in the pandemic, only patients with symptoms and exposure were being tested for COVID-19. They had to meet CDC requirements for testing. As test kits have become more available, many more patients are being tested without symptoms and without known exposure. We know of one facility that is testing EVERY PATIENT so there would be a Z code on every patient, testing negative, depending on circumstances. If no symptoms with no exposure documented then it would be Z11.59. These are typically considered screenings for COVID-19. Coders may also see patents screened before outpatient surgeries, or before going to a nursing home.
The information contained in this post is valid at the time of posting. Viewers are encouraged to research subsequent official guidance in the areas associated with the topic as they can change rapidly.
Practices have not seen many revisions to the Evaluation and Management (E/M) office / outpatient visit guidelines in three decades – until now. As of January 1, there are new E/M coding guidelines. We’ll get to those in a bit, but first let’s look at why they changed.
Pseudoseizures are a form of non-epileptic seizure. These are difficult to diagnose and oftentimes extremely difficult for the patient to comprehend. The term “pseudoseizures” is an older term that is still used today to describe psychogenic nonepileptic seizures (PNES).
With the implementation of ICD-10-CM came different codes and coding rules for many diagnoses. One of these is the coding of bowel obstruction when the patient presents for this condition that is caused by another condition.
This is Part 5 of a five part series on the new 2021 CPT codes. For the remaining areas we will just briefly summarize the section. Due to the intricate nature of these sections in CPT, it is recommended that the coder read the entire section notes associated with the new codes.
This is Part 4 of a five part series on the new 2021 CPT codes. In this series we will explore the CPT changes in the urinary, nervous, ocular and auditory systems. There are 2 new urinary/male reproductive system codes with no revisions or deletions; 3 new female reproductive codes with 2 deletions, 0 new with 4 deleted nervous system codes with 5 revisions; 5 new eye category III codes; and finally a 2 new auditory codes with one deletion.
This is Part 3 of a five part series on the new 2021 CPT codes. In this series we will explore the cardiovascular system CPT changes. There are 5 new cardiovascular CPT codes added with 0 deletions and 4 revisions.
This is Part 2 of a five part series on the new 2021 CPT codes. In this series we will explore the CPT changes for FY2021 and include some examples to help the coder understand the new codes. There are 0 new musculoskeletal CPT codes added with 0 deletions and 2 major revisions along with an extensive update to arthroscopic loose body removal requirements. For the respiratory system, there were 2 new codes, one code deletion and no revisions.
This is Part 1 of a five part series on the new 2021 CPT codes. In this series we will explore the CPT changes for FY2021 and include examples to help the coder understand the new codes. For 2021 in general, there were 199 new CPT codes added, 54 deleted and 69 revised.
In January, new CPT codes were released. There were 248 new CPT codes added, 71 deleted and 75 revised. Most of the surgery section changes were in the musculoskeletal and cardiovascular subsections. These included procedures such as skin grafting, breast biopsies, deep drug delivery systems, tricuspid valve repairs, aortic grafts and repair of iliac artery.
We have seen many updates and changes to COVID-19 (SARS-CoV-2) since the pandemic started. On January 1, 2021 we will see even more changes as outlined in this post. Also the CMS MS-DRG grouper will be updated to version 38.1 to accommodate the changes.
In the previous three parts of this four-part series, we discussed the new ICD-10-CM diagnosis code changes, ICD-10-PCS procedure code changes and FY2021 IPPS changes. In this last Part 4 of the series, we will review the NTAP procedure codes and reimbursement add-on payments for FY2021.
In the previous two parts of this four part series, we discussed the new ICD-10-CM diagnosis code changes and ICD-10-PC procedure code changes. In this session we will review the major IPPS changes for FY2021.
This is Part 2 of a 4 part series on the FY2021 ICD-10 Code and IPPS changes. In this part, the ICD-10-PCS procedure codes are presented. For FY2021 ICD-10-PCS there are 78,115 total codes (FY2020 total was 77,571); 556 new codes (734 new last year in FY2020)…
This is Part 1 of a 4 part series on the FY2021 changes to ICD-10 and the IPPS. In this part, we discuss some of the new ICD-10-CM diagnosis changes. Here is the breakdown: 72,616 total ICD-10-CM codes for FY2021; 490 new codes (2020 had 273 new codes); 58 deleted codes (2020 had 21 deleted codes); 47 revised codes (2020 had 30 revised codes)
Acute pulmonary edema is the rapid accumulation of fluid within the tissue and space around the air sacs of the lung (lung interstitium). When this fluid collects in the air sacs in the lungs it is difficult to breathe. Acute pulmonary edema occurs suddenly and is life threatening.
“Client S” is a small, not-for-profit, 40 bed micro-hospital in the Southeast. HIA performed a 65-record review this year for Client S and found an opportunity with 15 of them. 9 had an increased reimbursement with a total of $43,228 found.
The coma scale codes (R40.2-) can be used in conjunction with traumatic brain injury codes, acute cerebrovascular disease or sequelae of cerebrovascular disease codes. These codes are primarily for use by trauma registries, but they may be used in any setting where this information is collected. The coma scale may also be used to assess the status of the central nervous system for other non-trauma conditions, such as monitoring patients in the intensive care unit regardless of medical condition.
In the past, there had been an Excludes1 note at I46.- Cardiac arrest that excluded R57.0, Cardiac shock. HIA had also received a letter from AHA on a case in the past that had stated that only I46.- Cardiac arrest would be coded if both were documented. In addition, the Third Quarter Coding Clinic page 26 had a similar case that asked if both could be coded, and AHA had instructed that only I46.9, cardiac arrest, cause unspecified would be coded if both were documented and that the CDC would be looking at possible revision to the Excludes1 note.
A higher CMI corresponds to increased consumption of resources and increased cost of patient care, resulting in increased reimbursement to the facility from government and private payers, like CMS. We know that documentation directly impacts coding.
Lately we have seen several cases where the endarterectomy was assigned along with the coronary artery bypass (CABG) procedure when being performed on the same vessel to facilitate the CABG. A coronary artery endarterectomy is not always performed during a CABG procedure, so when it is performed it becomes confusing as to whether to code it separately or not.
Assign code Z20.828, “Contact with and (suspected) exposure to other viral communicable diseases” for all patients who are tested for COVID-19 and the results are negative, regardless of symptoms, no symptoms, exposure or not as we are in a pandemic.
The Centers for Medicare & Medicaid Services (CMS) announced new procedure codes for treatments of COVID-19 – effective as of August 1, 2020. Among the new codes are Section X New Technology codes for the introduction or infusion of therapeutics including Remdesivir, Sarilumab, Tocilizumab, transfusion of convalescent plasma, as well as introduction of any other or new therapeutic substances for the treatment of COVID-19.
One common element in many value-based programs is risk adjustment using Hierarchical Condition Categories (HCCs) to create a Risk Adjustment Factor (RAF) score. This method ranks diagnoses into categories that represent conditions with similar cost patterns.
In previous parts of this series we looked at the definitions of AKI/ARF, causes, coding and sequencing, and the common clinical indicators that patients present with that are diagnosed with this condition. In Part 4, we will look at the documentation that should be present to report the diagnosis without fear of denial, as well as when a query is needed to clarify the diagnosis.
In the first parts of this series we looked at definitions of AKI/ARF, causes, coding and sequencing. In Part 3, we will look at what clinical indicators would possibly be present to support the diagnosis of AKI/ARF.
The FY2021 IPPS Proposed Rule is out and here are some highlights from it regarding ICD-10 Code proposals. We will know if these changes are permanent after the public comment period is over on July 10, 2020 and CMS prepares the Final Rule, usually out by August 1.
As discussed in Part 1 of this series, AKI/ARF is a common diagnosis that coders see daily. In Part 2, we are going to focus on the different types/specificity of AKI/ARF. We’ll learn what they mean, as well as how to code the diagnosis.
This is part 1 in a series focused on coding of acute kidney injury (AKI) and/or acute renal failure (ARF). AKI/ARF is reported often, but is also one of the most common diagnosis found in denials.
With the proliferation of COVID-19 cases, we thought we would put together a quick reference listing of some of the common scenarios that coders have asked about. As with all coding, coders should follow Official Guidelines for Coding and Reporting and the COVD-19 Frequently Asked Questions document by the AHA.